{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T01:32:30Z","timestamp":1783733550017,"version":"3.55.0"},"reference-count":79,"publisher":"Elsevier BV","issue":"24","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T00:00:00Z","timestamp":1598572800000},"content-version":"vor","delay-in-days":819,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)","doi-asserted-by":"publisher","award":["HL116263"],"award-info":[{"award-number":["HL116263"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)","doi-asserted-by":"publisher","award":["HL138745"],"award-info":[{"award-number":["HL138745"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association (AHA)","doi-asserted-by":"publisher","award":["17POST33660332"],"award-info":[{"award-number":["17POST33660332"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1074\/jbc.ra117.001099","type":"journal-article","created":{"date-parts":[[2018,4,30]],"date-time":"2018-04-30T20:40:19Z","timestamp":1525120819000},"page":"9176-9187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Modification by isolevuglandins, highly reactive \u03b3-ketoaldehydes, deleteriously alters high-density lipoprotein structure and function"],"prefix":"10.1016","volume":"293","author":[{"given":"Linda S.","family":"May-Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valery","family":"Yermalitsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiansheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany","family":"Pleasent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S.","family":"Borja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael N.","family":"Oda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Gray","family":"Jerome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia G.","family":"Yancey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MacRae F.","family":"Linton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9879-8062","authenticated-orcid":false,"given":"Sean S.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.RA117.001099_bib1","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1161\/01.ATV.8.6.737","article-title":"High density lipoprotein cholesterol and mortality: the Framingham Heart Study","volume":"8","author":"Wilson","year":"1988","journal-title":"Arteriosclerosis"},{"key":"10.1074\/jbc.RA117.001099_bib2","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0002-9343(77)90874-9","article-title":"High density lipoprotein as a protective factor against coronary heart disease: the Framingham Study","volume":"62","author":"Gordon","year":"1977","journal-title":"Am. J. Med"},{"key":"10.1074\/jbc.RA117.001099_bib3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/01.CIR.79.1.8","article-title":"High-density lipoprotein cholesterol and cardiovascular disease: four prospective American studies","volume":"79","author":"Gordon","year":"1989","journal-title":"Circulation"},{"key":"10.1074\/jbc.RA117.001099_bib4","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/0002-9149(92)90550-I","article-title":"Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience): Prospective Cardiovascular Munster study","volume":"70","author":"Assmann","year":"1992","journal-title":"Am. J. Cardiol"},{"key":"10.1074\/jbc.RA117.001099_bib5","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrd2489","article-title":"Is raising HDL a futile strategy for atheroprotection?","volume":"7","author":"Joy","year":"2008","journal-title":"Nat. Rev. Drug. Discov"},{"key":"10.1074\/jbc.RA117.001099_bib6","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/jdi.12487","article-title":"Re-examining the high-density lipoprotein hypothesis","volume":"7","author":"Tan","year":"2016","journal-title":"J. Diabetes Investig"},{"key":"10.1074\/jbc.RA117.001099_bib7","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1172\/JCI118345","article-title":"Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response: loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures","volume":"96","author":"Van Lenten","year":"1995","journal-title":"J. Clin. Invest"},{"key":"10.1074\/jbc.RA117.001099_bib8","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrcardio.2015.124","article-title":"Dysfunctional HDL and atherosclerotic cardiovascular disease","volume":"13","author":"Rosenson","year":"2016","journal-title":"Nat. Rev. Cardiol"},{"key":"10.1074\/jbc.RA117.001099_bib9","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1161\/ATVBAHA.112.300133","article-title":"High-density lipoprotein function, dysfunction, and reverse cholesterol transport","volume":"32","author":"Fisher","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol"},{"key":"10.1074\/jbc.RA117.001099_bib10","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nrcardio.2010.222","article-title":"HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms","volume":"8","author":"Navab","year":"2011","journal-title":"Nat. Rev. Cardiol"},{"key":"10.1074\/jbc.RA117.001099_bib11","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1194\/jlr.M800607-JLR200","article-title":"HDL is the major lipoprotein carrier of plasma F2-isoprostanes","volume":"50","author":"Proudfoot","year":"2009","journal-title":"J. Lipid Res"},{"key":"10.1074\/jbc.RA117.001099_bib12","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0891-5849(90)90131-2","article-title":"Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury","volume":"9","author":"Janero","year":"1990","journal-title":"Free Radic. Biol. Med"},{"key":"10.1074\/jbc.RA117.001099_bib13","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1096\/fj.04-2330rev","article-title":"Isoprostanes: markers and mediators of oxidative stress","volume":"18","author":"Montuschi","year":"2004","journal-title":"FASEB J"},{"key":"10.1074\/jbc.RA117.001099_bib14","doi-asserted-by":"crossref","first-page":"13139","DOI":"10.1074\/jbc.274.19.13139","article-title":"Identification of extremely reactive gamma-ketoaldehydes (isolevuglandins) as products of the isoprostane pathway and characterization of their lysyl protein adducts","volume":"274","author":"Brame","year":"1999","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA117.001099_bib15","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0891-5849(91)90192-6","article-title":"Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes","volume":"11","author":"Esterbauer","year":"1991","journal-title":"Free Radic. Biol. Med"},{"key":"10.1074\/jbc.RA117.001099_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0005-2760(96)00160-9","article-title":"Macrophage recognition of LDL modified by levuglandin E2, an oxidation product of arachidonic acid","volume":"1344","author":"Hoppe","year":"1997","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1074\/jbc.RA117.001099_bib17","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1388-1981(00)00038-X","article-title":"Isolevuglandin-protein adducts in humans: products of free radical-induced lipid oxidation through the isoprostane pathway","volume":"1485","author":"Salomon","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1074\/jbc.RA117.001099_bib18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1050-1738(00)00040-2","article-title":"Isolevuglandin-protein adducts in oxidized low density lipoprotein and human plasma: a strong connection with cardiovascular disease","volume":"10","author":"Salomon","year":"2000","journal-title":"Trends Cardiovasc. Med"},{"key":"10.1074\/jbc.RA117.001099_bib19","doi-asserted-by":"crossref","first-page":"10316","DOI":"10.1073\/pnas.89.21.10316","article-title":"High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors","volume":"89","author":"Bowry","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA117.001099_bib20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1476-511X-4-25","article-title":"HDL enhances oxidation of LDL in vitro in both men and women","volume":"4","author":"Solakivi","year":"2005","journal-title":"Lipids Health Dis"},{"key":"10.1074\/jbc.RA117.001099_bib21","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1172\/JCI67478","article-title":"Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex","volume":"123","author":"Huang","year":"2013","journal-title":"J. Clin. Invest"},{"key":"10.1074\/jbc.RA117.001099_bib22","doi-asserted-by":"crossref","first-page":"6375","DOI":"10.1074\/jbc.M111.337345","article-title":"Myeloperoxidase targets apolipoprotein A-I, the major high density lipoprotein protein, for site-specific oxidation in human atherosclerotic lesions","volume":"287","author":"Shao","year":"2012","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA117.001099_bib23","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.freeradbiomed.2012.07.077","article-title":"Identification of novel bioactive aldehyde-modified phosphatidylethanolamines formed by lipid peroxidation","volume":"53","author":"Guo","year":"2012","journal-title":"Free Radic. Biol. Med"},{"key":"10.1074\/jbc.RA117.001099_bib24","doi-asserted-by":"crossref","first-page":"15756","DOI":"10.1021\/bi061860g","article-title":"Pyridoxamine analogues scavenge lipid-derived \u03b3-ketoaldehydes and protect against H2O2-mediated cytotoxicity","volume":"45","author":"Davies","year":"2006","journal-title":"Biochemistry"},{"key":"10.1074\/jbc.RA117.001099_bib25","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1161\/01.ATV.15.10.1599","article-title":"Inhibition of lecithin-cholesterol acyltransferase and modification of HDL apolipoproteins by aldehydes","volume":"15","author":"McCall","year":"1995","journal-title":"Arterioscler. Thromb. Vasc. Biol"},{"key":"10.1074\/jbc.RA117.001099_bib26","doi-asserted-by":"crossref","first-page":"e71541","DOI":"10.1371\/journal.pone.0071541","article-title":"HDL-apoA-I exchange: rapid detection and association with atherosclerosis","volume":"8","author":"Borja","year":"2013","journal-title":"PLoS One"},{"key":"10.1074\/jbc.RA117.001099_bib27","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1172\/JCI27602","article-title":"HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathway","volume":"116","author":"Matsuura","year":"2006","journal-title":"J. Clin. Invest"},{"key":"10.1074\/jbc.RA117.001099_bib28","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1161\/ATVBAHA.107.139592","article-title":"A pathway-dependent on apoE, ApoAI, and ABCA1 determines formation of buoyant high-density lipoprotein by macrophage foam cells","volume":"27","author":"Yancey","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol"},{"key":"10.1074\/jbc.RA117.001099_bib29","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/S0022-2275(20)33407-6","article-title":"Apolipoprotein E-dependent cholesterol efflux from macrophages: kinetic study and divergent mechanisms for endogenous versus exogenous apolipoprotein E","volume":"40","author":"Lin","year":"1999","journal-title":"J. Lipid Res"},{"key":"10.1074\/jbc.RA117.001099_bib30","doi-asserted-by":"crossref","first-page":"C586","DOI":"10.1152\/ajpcell.00210.2004","article-title":"ApoE-mediated cholesterol efflux from macrophages: separation of autocrine and paracrine effects","volume":"288","author":"Dove","year":"2005","journal-title":"Am. J. Physiol. Cell Physiol"},{"key":"10.1074\/jbc.RA117.001099_bib31","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0022-2275(20)42709-9","article-title":"In vitro incorporation of cholesterol-14C into very low density lipoprotein cholesteryl esters","volume":"9","author":"Akanuma","year":"1968","journal-title":"J. Lipid Res"},{"key":"10.1074\/jbc.RA117.001099_bib32","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1161\/01.ATV.0000148706.15947.8a","article-title":"Probucol inhibits ABCA1-mediated cellular lipid efflux","volume":"24","author":"Favari","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol"},{"key":"10.1074\/jbc.RA117.001099_bib33","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/ni.2784","article-title":"High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3","volume":"15","author":"De Nardo","year":"2014","journal-title":"Nat. Immunol"},{"key":"10.1074\/jbc.RA117.001099_bib34","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1161\/CIRCULATIONAHA.110.961193","article-title":"High-density lipoprotein suppresses the type I interferon response, a family of potent antiviral immunoregulators, in macrophages challenged with lipopolysaccharide","volume":"122","author":"Suzuki","year":"2010","journal-title":"Circulation"},{"key":"10.1074\/jbc.RA117.001099_bib35","doi-asserted-by":"crossref","first-page":"30825","DOI":"10.1074\/jbc.M109.047605","article-title":"Modification of high density lipoprotein by myeloperoxidase generates a pro-inflammatory particle","volume":"284","author":"Undurti","year":"2009","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA117.001099_bib36","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1089\/ars.2014.6078","article-title":"Isolevuglandin-type lipid aldehydes induce the inflammatory response of macrophages by modifying phosphatidylethanolamines and activating the receptor for advanced glycation endproducts","volume":"22","author":"Guo","year":"2015","journal-title":"Antioxid. Redox Signal"},{"key":"10.1074\/jbc.RA117.001099_bib37","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.numecd.2006.01.012","article-title":"Modified HDL: biological and physiopathological consequences","volume":"16","author":"Norata","year":"2006","journal-title":"Nutr. Metab. Cardiovasc Dis"},{"key":"10.1074\/jbc.RA117.001099_bib38","doi-asserted-by":"crossref","first-page":"17415","DOI":"10.1074\/jbc.M112400200","article-title":"A tale of two controversies: defining both the role of peroxidases in nitrotyrosine formation in vivo using eosinophil peroxidase and myeloperoxidase-deficient mice, and the nature of peroxidase-generated reactive nitrogen species","volume":"277","author":"Brennan","year":"2002","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA117.001099_bib39","doi-asserted-by":"crossref","first-page":"46116","DOI":"10.1074\/jbc.M209124200","article-title":"Myeloperoxidase functions as a major enzymatic catalyst for initiation of lipid peroxidation at sites of inflammation","volume":"277","author":"Zhang","year":"2002","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA117.001099_bib40","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1172\/JCI0215021","article-title":"Myeloperoxidase produces nitrating oxidants in vivo","volume":"109","author":"Gaut","year":"2002","journal-title":"J. Clin. Invest"},{"key":"10.1074\/jbc.RA117.001099_bib41","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1001\/jama.286.17.2136","article-title":"Association between myeloperoxidase levels and risk of coronary artery disease","volume":"286","author":"Zhang","year":"2001","journal-title":"JAMA"},{"key":"10.1074\/jbc.RA117.001099_bib42","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1056\/NEJMoa035003","article-title":"Prognostic value of myeloperoxidase in patients with chest pain","volume":"349","author":"Brennan","year":"2003","journal-title":"N. Engl. J. Med"},{"key":"10.1074\/jbc.RA117.001099_bib43","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1161\/01.CIR.0000090690.67322.51","article-title":"Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes","volume":"108","author":"Baldus","year":"2003","journal-title":"Circulation"},{"key":"10.1074\/jbc.RA117.001099_bib44","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1172\/JCI200421109","article-title":"Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease","volume":"114","author":"Zheng","year":"2004","journal-title":"J. Clin. Invest"},{"key":"10.1074\/jbc.RA117.001099_bib45","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1194\/jlr.R035725","article-title":"Proteomic diversity of high density lipoproteins: our emerging understanding of its importance in lipid transport and beyond","volume":"54","author":"Shah","year":"2013","journal-title":"J. Lipid Res"},{"key":"10.1074\/jbc.RA117.001099_bib46","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1016\/S0022-2275(20)34894-X","article-title":"Small HDL particles containing two apoA-I molecules are precursors in vivo to medium and large HDL particles containing three and four apoA-I molecules in nonhuman primates","volume":"40","author":"Colvin","year":"1999","journal-title":"J. Lipid Res"},{"key":"10.1074\/jbc.RA117.001099_bib47","doi-asserted-by":"crossref","first-page":"7615","DOI":"10.1074\/jbc.M111.291070","article-title":"Apolipoprotein A-II-mediated conformational changes of apolipoprotein A-I in discoidal high density lipoproteins","volume":"287","author":"Gauthamadasa","year":"2012","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA117.001099_bib48","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1021\/bi300555d","article-title":"Role of apolipoprotein A-II in the structure and remodeling of human high-density lipoprotein (HDL): protein conformational ensemble on HDL","volume":"51","author":"Gao","year":"2012","journal-title":"Biochemistry"},{"key":"10.1074\/jbc.RA117.001099_bib49","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.abb.2008.02.021","article-title":"The central type Y amphipathic \u03b1-helices of apolipoprotein AI are involved in the mobilization of intracellular cholesterol depots","volume":"473","author":"Gonzalez","year":"2008","journal-title":"Arch. Biochem. Biophys"},{"key":"10.1074\/jbc.RA117.001099_bib50","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1161\/CIRCOUTCOMES.113.000675","article-title":"High-density lipoprotein particle subclass heterogeneity and incident coronary heart disease","volume":"7","author":"Akinkuolie","year":"2014","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"10.1074\/jbc.RA117.001099_bib51","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12933-017-0570-2","article-title":"Reduced HDL function in children and young adults with type 1 diabetes","volume":"16","author":"Heier","year":"2017","journal-title":"Cardiovasc. Diabetol"},{"key":"10.1074\/jbc.RA117.001099_bib52","doi-asserted-by":"crossref","first-page":"e0182217","DOI":"10.1371\/journal.pone.0182217","article-title":"Apolipoprotein A-I exchange is impaired in metabolic syndrome patients asymptomatic for diabetes and cardiovascular disease","volume":"12","author":"Borja","year":"2017","journal-title":"PLoS One"},{"key":"10.1074\/jbc.RA117.001099_bib53","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1177\/1535370216657447","article-title":"Featured article: alterations of lecithin cholesterol acyltransferase activity and apolipoprotein A-I functionality in human sickle blood","volume":"241","author":"Soupene","year":"2016","journal-title":"Exp. Biol. Med"},{"key":"10.1074\/jbc.RA117.001099_bib54","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/QAI.0000000000001383","article-title":"Predictors of impaired HDL function in HIV-1 infected compared to uninfected individuals","volume":"75","author":"Kelesidis","year":"2017","journal-title":"J. Acquir. Immune Defic. Syndr"},{"key":"10.1074\/jbc.RA117.001099_bib55","doi-asserted-by":"crossref","first-page":"18847","DOI":"10.1074\/jbc.M109.098434","article-title":"Exchange of apolipoprotein A-I between lipid-associated and lipid-free states: a potential target for oxidative generation of dysfunctional high density lipoproteins","volume":"285","author":"Cavigiolio","year":"2010","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA117.001099_bib56","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1161\/01.ATV.0000075912.83860.26","article-title":"Regulation and mechanisms of ATP-binding cassette transporter A1-mediated cellular cholesterol efflux","volume":"23","author":"Wang","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol"},{"key":"10.1074\/jbc.RA117.001099_bib57","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1161\/01.ATV.0000057572.97137.DD","article-title":"Importance of different pathways of cellular cholesterol efflux","volume":"23","author":"Yancey","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol"},{"key":"10.1074\/jbc.RA117.001099_bib58","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/0005-2760(92)90050-6","article-title":"Malondialdehyde modification and copper-induced autooxidation of high-density lipoprotein decrease cholesterol efflux from human cultured fibroblasts","volume":"1125","author":"Salmon","year":"1992","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1074\/jbc.RA117.001099_bib59","doi-asserted-by":"crossref","first-page":"6457","DOI":"10.1073\/pnas.88.15.6457","article-title":"High density lipoprotein loses its effect to stimulate efflux of cholesterol from foam cells after oxidative modification","volume":"88","author":"Nagano","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA117.001099_bib60","doi-asserted-by":"crossref","first-page":"13032","DOI":"10.1073\/pnas.0405292101","article-title":"The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport","volume":"101","author":"Bergt","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA117.001099_bib61","doi-asserted-by":"crossref","first-page":"5983","DOI":"10.1074\/jbc.M411484200","article-title":"Tyrosine 192 in apolipoprotein A-I is the major site of nitration and chlorination by myeloperoxidase, but only chlorination markedly impairs ABCA1-dependent cholesterol transport","volume":"280","author":"Shao","year":"2005","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA117.001099_bib62","doi-asserted-by":"crossref","first-page":"6631","DOI":"10.1073\/pnas.90.14.6631","article-title":"Oxidative tyrosylation of high density lipoprotein by peroxidase enhances cholesterol removal from cultured fibroblasts and macrophage foam cells","volume":"90","author":"Francis","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA117.001099_bib63","doi-asserted-by":"crossref","first-page":"17391","DOI":"10.1074\/jbc.273.28.17391","article-title":"Enhanced cholesterol efflux by tyrosyl radical-oxidized high density lipoprotein is mediated by apolipoprotein AI-AII heterodimers","volume":"273","author":"Wang","year":"1998","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA117.001099_bib64","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/icb.2009.112","article-title":"HDL and immunomodulation: an emerging role of HDL against atherosclerosis","volume":"88","author":"Yu","year":"2010","journal-title":"Immunol. Cell Biol"},{"key":"10.1074\/jbc.RA117.001099_bib65","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1172\/JCI109610","article-title":"New function for high density lipoproteins: their participation in intravascular reactions of bacterial lipopolysaccharides","volume":"64","author":"Ulevitch","year":"1979","journal-title":"J. Clin. Invest"},{"key":"10.1074\/jbc.RA117.001099_bib66","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1172\/JCI110100","article-title":"New function for high density lipoproteins: isolation and characterization of a bacterial lipopolysaccharide-high density lipoprotein complex formed in rabbit plasma","volume":"67","author":"Ulevitch","year":"1981","journal-title":"J. Clin. Invest"},{"key":"10.1074\/jbc.RA117.001099_bib67","doi-asserted-by":"crossref","first-page":"12040","DOI":"10.1073\/pnas.90.24.12040","article-title":"In vivo protection against endotoxin by plasma high density lipoprotein","volume":"90","author":"Levine","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA117.001099_bib68","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1128\/iai.58.7.2375-2382.1990","article-title":"Cytokine response by monocytes and macrophages to free and lipoprotein-bound lipopolysaccharide","volume":"58","author":"Cavaillon","year":"1990","journal-title":"Infect. Immun"},{"key":"10.1074\/jbc.RA117.001099_bib69","doi-asserted-by":"crossref","first-page":"18170","DOI":"10.1074\/jbc.M110.213470","article-title":"Phosphatidylethanolamines modified by \u03b3-ketoaldehyde (\u03b3KA) induce endoplasmic reticulum stress and endothelial activation","volume":"286","author":"Guo","year":"2011","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA117.001099_bib70","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1172\/JCI74084","article-title":"DC isoketal-modified proteins activate T cells and promote hypertension","volume":"124","author":"Kirabo","year":"2014","journal-title":"J. Clin. Invest"},{"key":"10.1074\/jbc.RA117.001099_bib71","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1081\/SCC-200048945","article-title":"A simplified synthesis of the diastereomers of levuglandin E2","volume":"35","author":"Amarnath","year":"2005","journal-title":"Synth. Commun"},{"key":"10.1074\/jbc.RA117.001099_bib72","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1007\/BF02536025","article-title":"A facile synthesis of 4-hydroxy-2(E)-nonenal","volume":"27","author":"Gardner","year":"1992","journal-title":"Lipids"},{"key":"10.1074\/jbc.RA117.001099_bib73","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/ejoc.200900787","article-title":"Sequential Mannich-Aza-Michael reactions for the sterodivergent synthesis of highly substituted pyrrolidines","volume":"2009","author":"Enkisch","year":"2009","journal-title":"Eur. J. Org. Chem"},{"key":"10.1074\/jbc.RA117.001099_bib74","doi-asserted-by":"crossref","first-page":"38503","DOI":"10.1074\/jbc.M203318200","article-title":"Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36","volume":"277","author":"Podrez","year":"2002","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA117.001099_bib75","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/pharmaceutics2010018","article-title":"Determination of the pharmacokinetics and oral bioavailability of salicylamine, a potent \u03b3-ketoaldehyde scavenger, by LC\/MS\/MS","volume":"2","author":"Zagol-Ikapitte","year":"2010","journal-title":"Pharmaceutics"},{"key":"10.1074\/jbc.RA117.001099_bib76","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1038\/nprot.2007.298","article-title":"Measurement of chronic oxidative and inflammatory stress by quantification of isoketal\/levuglandin \u03b3-ketoaldehyde protein adducts using liquid chromatography tandem mass spectrometry","volume":"2","author":"Davies","year":"2007","journal-title":"Nat. Protoc"},{"key":"10.1074\/jbc.RA117.001099_bib77","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1161\/ATVBAHA.108.173815","article-title":"Apolipoprotein A-I tryptophan substitution leads to resistance to myeloperoxidase-mediated loss of function","volume":"28","author":"Peng","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol"},{"key":"10.1074\/jbc.RA117.001099_bib78","doi-asserted-by":"crossref","first-page":"33775","DOI":"10.1074\/jbc.M504092200","article-title":"Tyrosine modification is not required for myeloperoxidase-induced loss of apolipoprotein A-I functional activities","volume":"280","author":"Peng","year":"2005","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA117.001099_bib79","first-page":"e3810","article-title":"Cholesterol efflux assay","author":"Low","year":"2012","journal-title":"J. Vis. Exp"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820388918?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820388918?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.RA117.001099","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:19:22Z","timestamp":1648772362000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820388918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":79,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0021925820388918"],"URL":"https:\/\/doi.org\/10.1074\/jbc.ra117.001099","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modification by isolevuglandins, highly reactive \u03b3-ketoaldehydes, deleteriously alters high-density lipoprotein structure and function","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.RA117.001099","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by The American Society for Biochemistry and Molecular Biology, Inc.","name":"copyright","label":"Copyright"}]}}